BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's Disease (PD), Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) and Multiple Sclerosis (MS).
BrainStorm will carry out the clinical trials, optimize and generally move towards having a commercial, FDA-approved procedure.
http://www.brainstorm-cell.com/
BrainStorm will carry out the clinical trials, optimize and generally move towards having a commercial, FDA-approved procedure.
http://www.brainstorm-cell.com/